Ethical Questions Surround New At-Home HIV Test

The Takeaway

This week an advisory panel to the Food and Drug Administration voted unanimously to recommend the approval of the first-ever rapid, over-the-counter, completely in-home HIV test.  Though the FDA has approved other HIV test kits designed for at-home use in the past, those tests require a blood sample that must be sent in to a laboratory for development. The newly considered test kit – called the OraQuick In-Home HIV Test – simply requires a mouth swab and a 20-minute wait for results.
It’s estimated that approximately one-fifth of the 1.2 million HIV carriers in the United States are unaware of their infection, and advocates of OraQuick say the test would provide a new and powerful attack against the American HIV epidemic.
Art Caplan, a regular guest on The Takeaway, discusses whether this test kit is a game-changer in the fight against HIV/AIDS and whether the kit’s benefits outweigh the ethical holes facing home-testing. Caplan is a professor of bioethics at the University of Pennsylvania.

Kickstart The World’s fundraising drive!

The article you just read is free because dedicated readers and listeners like you chose to support our nonprofit newsroom. Our team works tirelessly to ensure you hear the latest in international, human-centered reporting every weekday. But our work would not be possible without you. We need your help.

Make a gift today to help us raise $67,000  by the end of the year and keep The World going strong. Every gift will get us one step closer to our goal!